Alzheimer's Disease Research Today is a free monthly online journal that collates and summarizes the latest research about Alzheimer's Disease, including details on diagnosis, memory loss, heredity, treatment, medication.

Volume 4 (2007), Issue 12 (December)

1. Clinical prediction of Alzheimer disease dementia across the spectrum of mild cognitive impairment.
   Arch Gen Psychiatry, 64(12): 1443-50. [Abstract] [Full-text]
2. Alpha7 nicotinic receptor up-regulation in cholinergic basal forebrain neurons in Alzheimer disease.
   Arch Neurol, 64(12): 1771-6. [Abstract] [Full-text]
3. Disruptive behavior as a predictor in Alzheimer disease.
   Arch Neurol, 64(12): 1755-61. [Abstract] [Full-text]
4. Leisure activity and cognitive decline in incident Alzheimer disease.
   Arch Neurol, 64(12): 1749-54. [Abstract] [Full-text]
5. Variability of age at onset in siblings with familial Alzheimer disease.
   Arch Neurol, 64(12): 1743-8. [Abstract] [Full-text]
6. Down-regulation of cAMP-dependent protein kinase by over-activated calpain in Alzheimer disease brain.
   J Neurochem, 103(6): 2462-70. [Abstract] [Full-text]
7. Paradoxical embolisation and cerebral white matter lesions in dementia.
   Br J Radiol, 81(961): 30-4. [Abstract] [Full-text]
8. Regional analysis of spontaneous MEG rhythms in patients with Alzheimer's disease using spectral entropies.
   Ann Biomed Eng, 36(1): 141-52. [Abstract] [Full-text]
9. Cognitive dysfunctions in mild Parkinson's disease dementia: comparison with patients having mild Alzheimer's disease and normal controls.
   Eur Neurol, 59(1): 49-54. [Abstract] [Full-text]
10. Positron emission tomography facilitates diagnosis of early-onset Alzheimer's disease.
    Eur Neurol, 59(1): 31-7. [Abstract] [Full-text]
11. Practical utility of urinary assay in the diagnosis of Alzheimer's disease: AlzheimAlert.
    Expert Rev Mol Diagn, 8(1): 21-8. [Abstract] [Full-text]
12. Galantamine in Alzheimer's disease.
    Expert Rev Neurother, 8(1): 9-17. [Abstract] [Full-text]
13. HMG-CoA reductase inhibitor simvastatin inhibits cell cycle progression at the G1/S checkpoint in immortalized lymphocytes from Alzheimer's disease patients independently of cholesterol-lowering effects.
    J Pharmacol Exp Ther, 324(1): 352-9. [Abstract] [Full-text]
14. Meta-analysis of genetic variability in the beta-amyloid production, aggregation and degradation metabolic pathways and the risk of Alzheimer's disease.
    Acta Neurol Scand, 117(1): 1-14. [Abstract] [Full-text]
15. Omega-3 fatty acid docosahexaenoic acid increases SorLA/LR11, a sorting protein with reduced expression in sporadic Alzheimer's disease (AD): relevance to AD prevention.
    J Neurosci, 27(52): 14299-307. [Abstract] [Full-text]
16. Pharmacokinetics and pharmacodynamics of the novel daily rivastigmine transdermal patch compared with twice-daily capsules in Alzheimer's disease patients.
    Clin Pharmacol Ther, 83(1): 106-14. [Abstract] [Full-text]
17. A positron emission tomography study to assess binding of lecozotan, a novel 5-hydroxytryptamine-1A silent antagonist, to brain 5-HT1A receptors in healthy young and elderly subjects, and in patients with Alzheimer's disease.
    Clin Pharmacol Ther, 83(1): 86-96. [Abstract] [Full-text]

© 2004-2008 Alzheimer's Disease Research Today. All Rights Reserved.